| Patents for A61P 19 - Drugs for skeletal disorders (81,981) |
|---|
| 12/27/2006 | CN1883576A Externally applied medicine for treating hyperosteogeny and intervertebral disc protrusion |
| 12/27/2006 | CN1883575A Chinese medicine for treating hyperosteogeny |
| 12/27/2006 | CN1883565A Gel for treating rheumatic arthritis and traumatic injury and method for preparing same |
| 12/27/2006 | CN1883536A Orally administered cervus and cucumis polypeptide composition and preparation method thereof |
| 12/27/2006 | CN1883534A Medicine for treating orthopaedics disease and preparation method thereof |
| 12/27/2006 | CN1883516A Pharmaceutical composition of 'Yunnan Baiyao' for replenishing kidney, strengthening waist, resisting inflammation, dissipating stasis and anaesthesia to ease pain |
| 12/27/2006 | CN1883511A Inclusion compound of ants supercritical extracts and preparation process thereof |
| 12/27/2006 | CN1883502A Medicinal ointment for treating burns and scalds |
| 12/27/2006 | CN1883491A Medical use of ginsenoside Rh 1 |
| 12/27/2006 | CN1883486A Method for preparing compound double-layered tablet of carisoprodol-aspirin |
| 12/27/2006 | CN1883483A An injection liquid for treating rheumatism |
| 12/27/2006 | CN1292001C Nucleus factor-kB p50 subunit antagonist peptide, preparation and application thereof |
| 12/27/2006 | CN1292000C Nucleus factor-kB p65 subunit combination peptide, preparation and application thereof |
| 12/27/2006 | CN1291988C Triazaspiro [5,5] undecane derivatrives and drugs containing the same as active ingredient |
| 12/27/2006 | CN1291984C 2-thio-substituted imidazole derivatives and use therof in pharmaceutical industry |
| 12/27/2006 | CN1291736C Pain stopping ointment for traumatic injury |
| 12/26/2006 | US7153997 N-hydroxyphenoxyphenyl derivatives of glycine or valine, e.g., N-[3,5-Dichloro-4-(4-hydroxy-3-isopropyl-5-methylphenoxy)benzoyl]glycine; treating metabolic disorders or diseases dependent upon the expression of a T3 regulated gene |
| 12/26/2006 | US7153963 Phenylalanine derivatives |
| 12/26/2006 | US7153959 treatment of tumor necrosis factor mediated disorders; asthma; inflammatory bowel disease; arthritis |
| 12/26/2006 | US7153958 Farnesyl transferase inhibiting benzoheterocyclic derivatives |
| 12/26/2006 | US7153951 A biologically active peptide at least 85% identical to a peptide: (a) X01ValSerGluX02GlnLeuX03HisX04X05GlyLysX06; (b) fragments containing amino acids 1-9, 1-10, 1-11, 1-12,(c) a salt or (d) N- or C- derivatives |
| 12/26/2006 | US7153887 Treatment anti-neutrophil cytoplasmic antibodies-associated vasculitis in a patient resistant to corticosteroid treatment by administering gusperimus or its salt in cycles |
| 12/26/2006 | US7153862 αv integrin receptor antagonists |
| 12/26/2006 | US7153861 5,6 -Trimethylenepyrimidin-4-one compounds |
| 12/26/2006 | US7153859 For prophylaxis and therapy of asthma, chronic obstructive pulmonary disease, chronic bronchitis, atopic dermatitis, urticaria, allergic rhinitis, allergic conjunctivitis, vernal conjunctivitis, eosinophilia, psoriasis, rheumatoid arthritis, septic shock, ulcerative colitis, Crohn's disease |
| 12/26/2006 | US7153857 antiinflammatory agents; antiarthritic agents; anticancer agents |
| 12/26/2006 | US7153856 Orally administering N-(2-chloro-6-methylphenyl)-2-[4-(4-(2-hydroxyethyl)piperazin-1-yl)-2-methylpyrimidin-6-ylamino]thiazole-5-carboxamide for treating cancer |
| 12/26/2006 | US7153836 Having 1-4 hydrophobic C 10-24 aliphatic, saturated or unsaturated hydrocarbon residue moieties covalently bound to a protein with a hedgehog N-terminal domain; includes auxiliary substances, detergents, stabilizers, matrix materials, suramin, heparin, anionic polysaccharides and/or sequestering agents |
| 12/26/2006 | US7153669 Nucleotide sequences coding protein for use in the diagnosis, treatment and prevention of autoimmune, cell proliferative and inflammatory diseases |
| 12/26/2006 | US7153507 A human monoclonal antibody specifically binds to human IL-15 and to inhibit IL-15-induced proinflammatory effects; tumor necrosis factor; antiinflammatory, -arthritic, -carcinogenic, proliferative agents; rheumatic diseases; transplants |
| 12/21/2006 | WO2006135915A2 Methods and compositions for treating degenerative bone disorders |
| 12/21/2006 | WO2006135109A1 Method for treatment of proliferative disease utilizing inhibition of formation of synoviolin homooligomer |
| 12/21/2006 | WO2006135069A1 Osteoclast differentiation/formation inhibitor, and screening method for prophylactic or therapeutic agent for metabolic bone disorder |
| 12/21/2006 | WO2006134955A1 1, 2-di(cyclic group)substituted benzene derivative |
| 12/21/2006 | WO2006084145A3 Methods of using il-1 antagonists to reduce c-reactive protein |
| 12/21/2006 | WO2006083673A3 Pyridine derivatives useful as inhibitors of c-jun n-terminal kinases |
| 12/21/2006 | WO2006056888A3 Glycine as a diet supplement for the treatment of health problems that result from underlying metabolic disorders |
| 12/21/2006 | US20060287536 Phenyl-thiophene type vitamin d receptor modulators |
| 12/21/2006 | US20060287374 Inhibitors of 11-beta-hydroxy steroid dehydrogenase type 1 |
| 12/21/2006 | US20060287373 Cathepsin cysteine protease inhibitors |
| 12/21/2006 | US20060287371 E.g., pentamethyl-16-[1-methyl-2-(2-methyl-4-thiazolyl)ethenyl]-1-aza-13(Z)-cyclohexadecene-2,6-dione and 4S-[4R*,7S*,8R*,9R*,15R*(E)]]-4,8-dihydroxy-5,5,7,9,13,16-hexamethyl-16-[1-methyl-2-(2-methyl-4-thiazolyl)ethenyl]-1-oxa-13-cyclohexadecene-2,6-dione; antiproliferative agents |
| 12/21/2006 | US20060287355 Imidazo and thiazolopyridines as jak3 kinase inhibitors |
| 12/21/2006 | US20060287354 Azaindole compounds as kinase inhibitors |
| 12/21/2006 | US20060287340 e.g. 5-(4-fluorophenyl)-N-[2-(1-methyl-2-oxo-1,7-diazaspiro[4,4]nonan-7-yl)-6-quinolinyl]-2-pyrimidinecarboxamide; melanin concentrating hormone receptor antagonist; central nervous system disorders, cardiovascular disorders and metabolic disorders |
| 12/21/2006 | US20060287338 Metalloproteinase inhibitor compounds |
| 12/21/2006 | US20060287326 17-Acetamido-4-azasteroid derivatives as androgen receptor modulators |
| 12/21/2006 | US20060287284 Pharmaceutical composition combining tenatoprazole and an anti-inflamatory agent |
| 12/21/2006 | US20060287223 Remodeling and glycoconjugation of peptides |
| 12/21/2006 | US20060286150 Prevent menopause syndrome; therapy for skin aging; topical applying |
| 12/21/2006 | US20060286125 Immunomodulation; Yatapoxvirus polypeptide; multiple sclerosis, psoriasis, atopic dermatitis, type 1 insulin-dependent diabetes mellitus, dermatitis, Sjoigren's syndrome, encephalitis, Reiter's syndrome, psoriatic arthritis, progressive systemic sclerosis, primary biliary cirrhosis |
| 12/21/2006 | US20060286087 Recombinant alpha-L-iduronidase, methods for producing and purifying the same and methods for treating diseases caused by deficiencies thereof |
| 12/21/2006 | US20060286084 Agent for promoting osteogenesis and/or inhibiting bone resorption |
| 12/21/2006 | DE202006012266U1 Natural healing and care oil, useful e.g. for treating wounds, joint pain and rheumatism, comprises extra virgin olive oil and tincture of propolis |
| 12/21/2006 | CA2612298A1 Anti-inflammatory agents |
| 12/21/2006 | CA2607054A1 1, 2-di(cyclic group)substituted benzene derivative |
| 12/20/2006 | EP1733740A1 Therapeutic agent for auris interna disorder containing il-6 antagonist as active ingredient |
| 12/20/2006 | EP1733732A1 Insulin resistance improving agent |
| 12/20/2006 | EP1733726A1 Pharmaceutically active isoindoline derivatives |
| 12/20/2006 | EP1733724A1 Amino alcohol compound |
| 12/20/2006 | EP1732896A1 Substituted pyridones as inhibitors of poly(adp-ribose) polymerase (parp) |
| 12/20/2006 | EP1732592A1 Use of neuropeptides for ligament healing |
| 12/20/2006 | EP1732589A2 Bmp-3 propeptides and related methods |
| 12/20/2006 | EP1732575A1 Strontium-containing compounds for use in the prevention or treatment of necrotic bone conditions |
| 12/20/2006 | EP1732559A2 Methods of treatment using eszopiclone |
| 12/20/2006 | EP1732543A2 Tetra-cyclic carboline deratives for inhibiting angiogenesis |
| 12/20/2006 | EP1732531A2 Amines and amides for the treatment of diseases |
| 12/20/2006 | EP1656150B1 Use of bacilli bacteria for the prevention of vertebral compression syndrome in salmonids |
| 12/20/2006 | EP1551822B1 Pentacyclic oxepines and derivatives thereof, process for their preparation and pharmaceutical compositions containing them |
| 12/20/2006 | EP1542977B1 2,5-dioxoimidazolidin-4-yl acetamides and analogues as inhibitors of metalloproteinase mmp12. |
| 12/20/2006 | EP1390362B1 Substituted benzofurans and benzothiophenes, methods of making and methods of use as integrin antagonists |
| 12/20/2006 | EP1357903B1 STABILIZED FORMULATIONS OF 6-HYDROXY-3-(4- 2-(PIPERIDIN-1-YL) ETHOXY|PHENOXY)-2-(4-METHOXYPHENYL) BENZO b|THIOPHENE AND SALTS THEREOF |
| 12/20/2006 | EP1272457B9 Compounds for modulating cell proliferation |
| 12/20/2006 | EP1256344B1 Remedies for endothelin-induced diseases |
| 12/20/2006 | EP1187816B1 5-cyano-2-aminopyrimidine derivatives |
| 12/20/2006 | EP1131294B1 Quinoline derivatives as nk-2 and nk-3 receptor ligands |
| 12/20/2006 | EP1027027B1 Use of amylin, adrenomedullin and analogues thereof for treating cartilage defects |
| 12/20/2006 | CN1882343A Use of cathepsin k inhibitors for treating of severe bone loss diseases |
| 12/20/2006 | CN1880306A Substituted indeno[1,2-c]isoquinoline derivatives and methods of use thereof |
| 12/20/2006 | CN1879882A Combine injection formulation |
| 12/20/2006 | CN1879881A Yeast vaccine production method |
| 12/20/2006 | CN1879865A Soup medicine for treating cervical vertebra syndrome and its preparation method |
| 12/20/2006 | CN1879858A Fracture healing pills |
| 12/20/2006 | CN1879856A An externally applied ointment |
| 12/20/2006 | CN1879846A A Chinese medicinal preparation for treating rheumatism, hyperosteogeny and osteoporosis and method for preparing same |
| 12/20/2006 | CN1879833A An wind-expelling ointment and method for preparing same |
| 12/20/2006 | CN1879817A Medicine for treating Bi syndrome and method for preparing same |
| 12/20/2006 | CN1879809A A Chinese medicinal ointment for treating bone fracture |
| 12/20/2006 | CN1879776A Ointment for treating bone fracture |
| 12/20/2006 | CN1879772A Wind-expelling cold-clearing Dog skin plaster |
| 12/20/2006 | CN1879766A Medicine for treating rheumatism and preparation method thereof |
| 12/20/2006 | CN1879760A Compound medicine for treating high paralysis, fracture sequelae, cardiac infarction and splenomegaly |
| 12/20/2006 | CN1879749A Medicinal heath wine |
| 12/20/2006 | CN1879748A A group of compound Chinese medicinal oral preparation for treating osteoporosis and preparation method thererof |
| 12/20/2006 | CN1879723A Meridian obstruction dredging pills |
| 12/20/2006 | CN1879722A A medicine for treating rheumatic arthritis |
| 12/20/2006 | CN1879721A A compound capsule for treating Bi syndrome |
| 12/20/2006 | CN1879715A Chinese medicine for wax therapy of cervical spondylosis |
| 12/20/2006 | CN1879685A Chinese medicine for wax therapy of bone fracture |
| 12/20/2006 | CN1879678A Medicinal pills for treating rheumatism |
| 12/20/2006 | CN1879630A Pharmaceutical compositions and uses for androst-5-ene-3 beta,17 beta-diol |